New drug trial targets cancer in HIV patients
NCT ID NCT03601806
Summary
This study tested whether the drug pomalidomide could safely help control Kaposi sarcoma, a cancer that often affects people with HIV. It involved 26 HIV-positive adults in sub-Saharan Africa who took the drug daily in repeating cycles. Researchers measured how well the drug shrank tumors and monitored its side effects and impact on the patients' HIV status.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moi University School of Medicine
Eldoret, Kenya
-
UNC Project Malawi
Lilongwe, Malawi
-
Uganda Cancer Institute
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.